AlpalifeBio provides customized services for nanobody drugs R&D at various stages, such as nanobody/VHH discovery, humanization, affinity maturation and cell-based functional evaluation. We also provide services of expression, purification, and functional evaluation of GPCRs, an important family of drug target proteins.

Our company has a laboratory area of 28,000 sq. ft. with more than one hundred employees led by famous senior scientists. The company uses the camelid nanobody discovery platform to provide services such as antigen preparation, immunization, phage library construction and screening for VHH nanobody drug candidates with high affinity and specificity.